We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
-18.56%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.67B
AUM Growth
-$412M
(-20%)
Cap. Flow
+$65.2M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SDRL
Seadrill Limited Common Stock
SDRL
|
+$25.6M |
| 2 |
Vipshop
VIPS
|
+$16.3M |
| 3 |
DigitalBridge
DBRG
|
+$15.8M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$10.9M |
| 5 |
ALBO
Albireo Pharma Inc
ALBO
|
+$5.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$57.6M |
| 2 |
Bath & Body Works
BBWI
|
+$22.6M |
| 3 |
Bilibili
BILI
|
+$13M |
| 4 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$12.3M |
| 5 |
Gilead Sciences
GILD
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.37% |
| 2 | Financials | 7.66% |
| 3 | Consumer Discretionary | 5.31% |
| 4 | Communication Services | 3.82% |
| 5 | Industrials | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Philip Morris
PM
$297B
| $533K | 0.03% |
8,000
-27,000
| -77% | -$2.26M |
|
202
Novartis
NVS
$297B
| $532K | 0.03% |
6,919
| – | – |
|
203
Cartesian Therapeutics
RNAC
$229M
| $531K | 0.03% |
+5,767
| New | +$1.32M |
|
204
Cummins
CMI
$87.5B
| $530K | 0.03% |
4,000
| – | – |
|
205
Corvus Pharmaceuticals
CRVS
$1.12B
| $523K | 0.03% |
+158,982
| New | +$1.08M |
|
206
CF Industries
CF
$19.2B
| $521K | 0.03% |
+11,973
| New | +$562K |
|
207
CytomX Therapeutics
CTMX
$675M
| $517K | 0.03% |
+35,245
| New | +$523K |
|
|
FL
208
DELISTED
Foot Locker
FL
| $508K | 0.03% |
9,790
| – | – |
|
209
Viking Therapeutics
VKTX
$3.7B
| $505K | 0.03% |
+69,203
| New | +$827K |
|
210
Rogers Communications
RCI
$18.3B
| $502K | 0.03% |
5,540
+740
| +15% | +$38.4K |
|
211
NVIDIA
NVDA
$4.86T
| $500K | 0.03% |
152,400
-83,200
| -35% | -$398K |
|
212
American Express
AXP
$227B
| $498K | 0.03% |
5,255
+1,755
| +50% | +$184K |
|
|
MDSO
213
DELISTED
Medidata Solutions, Inc.
MDSO
| $498K | 0.03% |
7,600
| – | – |
|
214
Kinross Gold
KGC
$27.4B
| $486K | 0.03% |
150,000
| – | – |
|
|
PVLA
215
Palvella Therapeutics
PVLA
$1.99B
| $479K | 0.03% |
+2,346
| New | +$728K |
|
216
Abeona Therapeutics
ABEO
$366M
| $477K | 0.03% |
+2,876
| New | +$627K |
|
217
Bread Financial
BFH
$4.37B
| $465K | 0.03% |
3,884
| – | – |
|
218
Nutrien
NTR
$33.2B
| $451K | 0.03% |
+6,400
| New | +$334K |
|
|
MLNT
219
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $449K | 0.03% |
+98,592
| New | +$1.26M |
|
|
MTEM
220
DELISTED
Molecular Templates, Inc.
MTEM
| $427K | 0.03% |
+7,802
| New | +$544K |
|
|
INFI
221
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $424K | 0.03% |
378,296
+19,437
| +5% | +$35K |
|
|
FOCL
222
EDAP TMS S.A.
FOCL
$229M
| $421K | 0.03% |
249,143
+78,516
| +46% | +$197K |
|
223
Ligand Pharmaceuticals
LGND
$5.76B
| $411K | 0.02% |
4,809
| – | – |
|
224
NextEra Energy
NEE
$181B
| $408K | 0.02% |
9,480
-42,800
| -82% | -$1.87M |
|
225
Skyworks Solutions
SWKS
$9.37B
| $406K | 0.02% |
6,000
| – | – |
|
Similar funds
NC
T2I
BA
IAA
THL
MHC
BWM
KHCM
Fosun International's Q4 2018 Portfolio in Review
As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.
- Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
- Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
- Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
- Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
- Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
- Fosun International opened 97 new positions and closed 44 in Q4 2018.
- Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.
Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.